Esperion Therapeutics, Inc. (ESPR) Insider Ownership

Historic Insider Ownership Trends

Esperion Therapeutics's three largest insider shareholders as of April 22, 2026 are Benjamin Halladay (Chief Financial Officer, 713.60K shares), Benjamin Looker (Chief Legal Officer, 679.35K shares), John B. Jr. Harlow (Chief Commercial Officer, 424.54K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Benjamin Halladay Chief Financial Officer 713,602 0 18 Mar, 2026
Benjamin Looker Chief Legal Officer 679,348 0 18 Mar, 2026
John B. Jr. Harlow Chief Commercial Officer 424,536 0 08 Dec, 2025
Eric Warren Chief Commercial Officer 370,218 0 21 Apr, 2025
Joanne M. Foody Chief Medical Officer 272,862 0 18 Jul, 2024
J Martin Carroll - 97,650 0 02 Jun, 2025
Jay Shepard - 84,599 0 02 Jun, 2025
Richard Bartram Chief Financial Officer 82,751 0 16 Mar, 2022
Stephen Rocamboli - 69,261 0 02 Jun, 2025
Seth H. Z. Fischer - 61,150 0 02 Jun, 2025
Antonio M Jr Md D Phil Gotto - 51,599 0 23 May, 2024
Nicole Vitullo - 36,918 0 16 Jun, 2023
Tracy M Woody - 33,566 0 16 Jun, 2023
Robert E. Hoffman - 5,280 0 02 Jun, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
17 Mar, 2026 Benjamin Halladay Common Stock D 6,424 $2.71 713,602 D S
17 Mar, 2026 Benjamin Looker Common Stock D 5,708 $2.70 679,348 D S
13 Mar, 2026 Benjamin Looker Common Stock A 300,840 $0.00 685,056 D A
13 Mar, 2026 Benjamin Halladay Common Stock A 247,430 $0.00 720,026 D A
13 Mar, 2026 Benjamin Looker Stock Option (right to buy) A 269,230 $0.00 269,230 D A
13 Mar, 2026 Benjamin Halladay Stock Option (right to buy) A 221,270 $0.00 221,270 D A
20 Jan, 2026 Benjamin Looker Common Stock D 1,689 $2.88 384,216 D S
17 Dec, 2025 Benjamin Halladay Common Stock D 7,337 $3.67 467,525 D S
17 Dec, 2025 Benjamin Looker Common Stock D 6,517 $3.67 385,905 D S
04 Dec, 2025 John B. Jr. Harlow Common Stock A 424,536 $0.00 424,536 D A
04 Dec, 2025 John B. Jr. Harlow Stock Option (right to buy) A 380,000 $0.00 380,000 D A
17 Oct, 2025 Benjamin Looker Common Stock D 1,248 $2.62 392,422 D S
17 Sep, 2025 Benjamin Looker Common Stock D 6,267 $2.80 393,670 D S
17 Sep, 2025 Benjamin Halladay Common Stock D 7,046 $2.81 474,862 D S
17 Jul, 2025 Benjamin Looker Common Stock D 1,304 $1.13 399,937 D S
17 Jul, 2025 Benjamin Halladay Common Stock D 11 $1.12 474,462 D S
17 Jun, 2025 Benjamin Halladay Common Stock D 7,229 $1.15 474,473 D S
17 Jun, 2025 Benjamin Looker Common Stock D 6,422 $1.15 401,241 D S
29 May, 2025 Robert E. Hoffman Common Stock A 5,280 $0.00 5,280 D A
29 May, 2025 Seth H. Z. Fischer Common Stock A 33,000 $0.00 61,150 D A